¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Superficial injury of trunk, level unspecified"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • superficial caries
    Ç¥¸é¿ì½Ä
  • superficial cellulitis
    Ç¥À翬Á¶Á÷¿°
  • superficial cleavage
    Ç¥ÃþºÐÇÒ
  • superficial cutaneous lipomatosus nevus
    ¾èÀºÇǺÎÁö¹æÁ¾¸ð¹Ý
  • superficial epigastric artery
    ¾èÀº¹èº®µ¿¸Æ, õº¹º®µ¿¸Æ
  • superficial fascia
    ¾èÀº±Ù¸·, õ±Ù¸·
  • superficial infection
    ¾èÀº°¨¿°, Ç¥Àç°¨¿°
  • superficial inguinal ring
    ¾èÀº»ô±¼±¸¸Û, Ç¥Àç¼­Çý°ø
  • superficial irradiation
    ¾èÀºÁ¶»ç, Ç¥ÀçÁ¶»ç
  • superficial leiomyoma
    ¾èÀºÆòȰ±ÙÁ¾, Ç¥À缺ÆòȰ±ÙÁ¾
  • superficial musculo-aponeurotic system
    ¾ó±¼³ÎÈûÁÙ°èÅë, Ç¥Àç±Ù°Ç¸·°èÅë
  • superficial musculo-aponeurotic system platysma flap
    ¾ó±¼³ÎÈûÁÙ°èÅë³ÐÀº¸ñ±ÙÆÇ, Ç¥Àç±Ù°Ç¸·°èÅëȰ°æ±ÙÆÇ
  • superficial palmar arch
    ¾èÀº¼Õ¹Ù´Úµ¿¸ÆÈ°, Ç¥Àç¼öÀå±Ã
  • superficial perineal space
    ¾èÀº»ô°ø°£, Ç¥ÀçȸÀ½°ø°£
  • superficial peroneal nerve
    ¾èÀºÁ¾¾Æ¸®½Å°æ, Ç¥Àçºñ°ñ½Å°æ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • injury
    ¼Õ»ó
  • ischemic injury
    ÇãÇ÷¼Õ»ó
  • pancreatic injury
    ÀÌÀÚ¼Õ»ó
  • penetrating injury
    °üÅë»ó
  • radiation injury
    ¹æ»ç¼±¼Õ»ó
  • sharp injury
    »ÏÁ·¼Õ»ó, ¿¹»ó
  • spinal cord injury
    ô¼ö¼Õ»ó
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • superficial epigastric artery
    ¾èÀº¹èº®µ¿¸Æ
  • superficial palmar arch
    ¾èÀº¼Õ¹Ù´Úµ¿¸ÆÈ°
  • superficial caries
    Ç¥¸é¿ì½Ä
  • superficial cellulitis
    Ç¥À翬Á¶Á÷¿°
  • superficial cleavage
    Ç¥ÃþºÐÇÒ
  • persistent superficial dermatitis
    Áö¼ÓÇ¥ÀçÇǺο°
  • superficial dermatophytosis
    ÇǺι鼱Áõ
  • superficial fascia
    ¾èÀº±Ù¸·
  • superficial pustular folliculitis
    Ç¥ÃþÀÜ°í¸§ÁýÅÐÁý¿°
  • superficial infection
    Ç¥Àç°¨¿°
  • superficial irradiation
    ±ÙÁ¢Á¶»ç
  • superficial punctate keratitis
    Ç¥ÃþÁ¡»ó°¢¸·¿°
  • superficial leiomyoma
    Ç¥ÀçÆòȰ±ÙÁ¾
  • superficial spreading melanoma
    ¾èÀºÈ®»ê¾Ç¼ºÈæ»öÁ¾
  • superficial cutaneous lipomatosus nevus
    ¾èÀºÇǺÎÁö¹æÁ¾¸ð¹Ý
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • EPNDB=ÊÝeffective perceived noise level
    ½ÇÈ¿°¨¼ö¼ÒÀ½·¹º§.
  • acceptable noise level
    Çã¿ë¼ÒÀ½
  • air fluid level
    °ø±â ¾×üÃþ
  • antimicrobial level
    Ç×±ÕÁ¦Ä¡<¼öÁØ(â©ñÞ)>
  • glucose level
    Æ÷µµ´çÄ¡<--ÁØÀ§>
  • ground water level
    ÁöÇϼö³ôÀÌ.
  • intensity level
    °­µµ¼öÁØ(Ë­öôâ©ñÞ).
  • power level
    ÆÄ¿ì¾î·¹º§.
  • acoustic injury
    À½Çâ(¼º) ¼Õ»ó
  • actinic injury
    ±¤¼±¼Õ»ó
  • air blast injury
    °ø±âÆø¾Ð»ó(ÍöѨøëäâßÒ), ÆøÇ³¼º ¼Õ»ó(øìù¦àõáßß¿)
  • free radical formation,irradation injury
    ÀÚÀ¯ ·¡µðÄ® Çü¼º, ¹æ»ç¼± ¼Õ»ó(Û¯ÞÒàÊ áßß¿)
  • gunshot injury
    ̄ȗ(̄ȗ).
  • hand injury
    ¼öÀÇ ¿Ü»ó(¼ö¡­¿Ü»ó), ¼Õ¿Ü»ó (¡­¿Ü»ó).
  • hand injury
    ¼öÀÇ ¿Ü»ó(⢡­èâß¿), ¼Õ ¿Ü»ó (¡­èâß¿)£¬¼öºÎ ¼Õ»ó£¨â¢Ý»áßß¿£©£¬¼Õ ¼Õ»ó£¨£­áßß¿£©.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • inferior trunk
    ¾Æ·¡ÁÙ±â
  • interlobar trunk
  • intestinal trunk
    âÀÚ¸²ÇÁ°üÁÙ±â
  • jugular trunk
    °æ¸²ÇÁ°£.
  • lateral basal branch artery of basal trunk<³ª> ramus basalis lateralis (partis basalis)
    ¿ÜÃøÆóÀúµ¿¸Æ.
  • left bronchomediastinal trunk
    ¿Þ±â°üÁö¼¼·ÎÄ­¸²ÇÁ°üÁÙ±â
  • left jugular trunk
    ¿Þ¸ñ¸²ÇÁ°üÁÙ±â
  • left lumbar lymphatic trunk
    ¿ÞÇ㸮¸²ÇÁ°üÁÙ±â
  • left subclavian trunk
    ¿ÞºøÀ幨¸²ÇÁ°üÁÙ±â
  • linguofacial trunk
    ¼³¾È¸éµ¿¸Æ
  • linguofacial trunk
    ¼³¾È¸éµ¿¸Æ(°£).
  • linguofacial trunk
    (Çô¾ó±¼µ¿¸Æ)
  • linguofacial trunk ; truncus linguofacialis ³ª
    ¼³¾È¸éµ¿¸Æ(°£).
  • lumbosacral trunk
    ¿äõ°ñ½Å°æ°£(é¦ô¾Íé ãêÌèÊÏ).
  • lumbosacral trunk
    Ç㸮¾ûÄ¡½Å°æÁÙ±â
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • Right subclavian trunk
    ¿À¸¥ºøÀ幨¸²ÇÁ°üÁÙ±â
    [¿¾ ¿ë¾î] ¿ì¼â°ñÇÏÀÓÆÄº»°£
  • Right lumbar lymphatic trunk
    ¿À¸¥Ç㸮¸²ÇÁ°üÁÙ±â
    [¿¾ ¿ë¾î] ¿ìÀÓÆÄº»°£
  • Left bronchomediastinal trunk
    ¿Þ±â°üÁö¼¼·ÎÄ­¸²ÇÁ°üÁÙ±â
    [¿¾ ¿ë¾î] Á±â°üÁöÁ¾°ÝÀÓÆÄº»°£
  • Left jugular trunk
    ¿Þ¸ñ¸²ÇÁ°üÁÙ±â
    [¿¾ ¿ë¾î] Á°æÀÓÆÄº»°£
  • Left subclavian trunk
    ¿ÞºøÀ幨¸²ÇÁ°üÁÙ±â
    [¿¾ ¿ë¾î] Á¼â°ñÇÏÀÓÆÄº»°£
  • Left lumbar lymphatic trunk
    ¿ÞÇ㸮¸²ÇÁ°üÁÙ±â
    [¿¾ ¿ë¾î] Á¿äÀÓÆÄº»°£
  • Intestinal trunk
    âÀÚ¸²ÇÁ°üÁÙ±â
    [¿¾ ¿ë¾î] ÀåÀÓÆÄº»°£
  • Spinal nerve trunk
    ô¼ö½Å°æÁÙ±â
    [¿¾ ¿ë¾î] ô¼ö½Å°æ°£
  • Brachiocephalic trunk
    ÆÈ¸Ó¸®µ¿¸Æ
    [¿¾ ¿ë¾î] ¿ÏµÎµ¿¸Æ
  • Brachiocephalic trunk
    ÆÈ¸Ó¸®µ¿¸Æ
    [¿¾ ¿ë¾î] ¿ÏµÎµ¿¸Æ°£
  • Lumbosacral trunk
    Ç㸮¾ûÄ¡½Å°æÁÙ±â
    [¿¾ ¿ë¾î] ¿äõ°ñ½Å°æ°£
  • Pulmonary trunk
    ÇãÆÄµ¿¸Æ
    [¿¾ ¿ë¾î] Æóµ¿¸Æ
  • Bifurcation of pulmonary trunk
    ÇãÆÄµ¿¸Æ°¥¸²
    [¿¾ ¿ë¾î] Æäµ¿¸ÆÀ̺Ð
  • Orifice of pulmonary trunk
    ÇãÆÄµ¿¸Æ±¸¸Û
    [¿¾ ¿ë¾î] Æóµ¿¸Æ±¸
  • Sinus of pulmonary trunk
    ÇãÆÄµ¿¸Æµ¿±¼
    [¿¾ ¿ë¾î] Æóµ¿¸Æµ¿
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • carinal level
    ºÐ±â ´ë
  • fat blood level
    Áö¹æÇ÷Ãþ
  • fluid fluid level
    ¾×ü¾×üÃþ
  • fluid level
    ¾×ü Ãþ, ¼öÀ§
  • level
    ´ë, ¼öÁØ
  • sedimentation level
    ħÀüÃþ
  • window level
    â³ôÀÌ
  • blast injury
    ÆøÇ³¼Õ»ó
  • blunt injury
    µÐ»ó
  • burst injury
    Æø¹ßºÎ»ó
  • contre coup injury
    ¹ÝÃæ¼Õ»ó
  • coup injury
    Ÿ°Ý¼Õ»ó
  • craniocerebral injury
    µÎ°³³ú¼Õ»ó, µÎ³ú¿Ü»ó
  • explosion injury
    Æø¹ß»ó
  • gunshot injury
    ̄ȗ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
NBI neutrophil bactericidal index; no bone injury; non-battle injury
PI first meiotic prophase; isoelectric point; pacing impulse; package insert; pancreatic insufficiency;...
PRICES protection, rest, ice, compression, elevation, support [primary treatment of tendinitis and overuse ...
PT   1) Prothrombin Time
  2) Physical Therapy; ¹°¸®¿ä¹ý
  3) Pulmonary...
BCAT brachiocephalic arterial trunk
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
S Superficial
SSM Superficial Spreading Melanoma
SGL Superficial gray layer
SMAS Superficial musculoaponeurotic system
STA Superficial temporal artery
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • anterior palate vault level
    Àü±¸°³Á¤ ³ôÀÌ
  • antimicrobial level
    Ç×±ÕÁ¦Ä¡
  • blood alcohol level
    Ç÷Áß ¾ËÄÚ¿Ã ³óµµ
  • blood oxygenation level dependant
    Ç÷Áß »ê¼ÒÄ¡ ÀÇÁ¸
  • c-AMP level
    ȯ½Ä AMP ·¹º§
  • carinal level
    ºÐ±â ´ë
  • elevated transaminase level

    elevation (°Å»ó, »ó½Â, À¶±â, °íÀ§

    À§·Î ¿Ã¶ó°¨. ¾î´À ÇÑ ºÎºÐÀÌ ³ôÀÌ ¼Ú¾Æ ¿À¸§. µé¾î¿Ã¸° ºÎÀ§, ¶Ç´Â Á»´õ ³ôÀº Á¡.
  • fasting blood sugar level
    °øº¹ ½Ã Ç÷´çÄ¡
  • level
    ¼öÁØ, ±íÀÌ, Ä¡, ´ÜÀ§, Ãþ, À§, ³ôÀÌ, ¹üÀ§, ¼öÁرâ, ÁØÀ§
  • maximal expiratory level
    ÃÖ´ë È£±âÀ§
  • maximal inspiratory level
    ÃÖ´ë Èí±âÀ§
  • mucosal level
    Á¡¸· ¼öÁØ
  • permissible radiation exposure level
    »ç¼± ³ëÃâ Çã¿ë·®
  • subconscious level
    ÀáÀç ÀÇ½Ä ¼öÁØ
  • substrate level phosphorylation
    ±âÁú±Þ ÀλêÈ­
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
serum iron level A test that measures the amount of iron (Fe ++) in the blood. The test is performed when iron deficiency is suspected. Normal serum iron is 60 to 170 mcg/dl. Increased levels may be seen in the following: haemochromatosis, haemolysis, haemolytic anaemia, hepatitis, liver necrosis, haemosiderosis, iron poisoning and lead toxicity. Lower than normal levels are seen in chronic GI blood loss, iron deficiency anaemia, insufficient dietary iron, malabsorption, chronic heavy menstrual bleeding, nephrosis and late pregnancy.
(27 Sep 1997)
sound pressure level A measure of sound energy relative to 0.0002 dynes/cm2, expressed in decibels.
(05 Mar 2000)
substrate-level phosphorylation Synthesis of high-energy phosphate bonds through reaction of inorganic phosphate with an activated (usually) organic substrate.
(09 Oct 1997)
no-observed-adverse-effect level The highest dosage administered that does not produce toxic effects. The noael will depend on how closely dosages are spaced (lowest-observed-adverse-effect level and no-observed-effect level) and the number of animals examined. The ultimate objective is usually to determine not the "safe" dosage in laboratory animals but the "safe" dosage for humans. Therefore, the extrapolation most often required of toxicologists is from high-dosage studies in laboratory animals to low doses in humans. (casarett and doull's toxicology: the basic science of poisons, 4th ed)
(12 Dec 1998)
organic level The amount of organic matter prescribed to be left after logging.
(05 Dec 1998)
trophic level <biology> Stage in a food chain or web leading from primary producers (lowest trophic level) through herbivores to primary and secondary carnivores (consumers- highest level).
(09 Oct 1997)
lactate level A test that measures the amount of lactic acid in the blood. Lactic acid is an intermediate product of carbohydrate metabolism and is derived mainly from muscle cells and red blood cells. Exercise will normally raise lactic acid levels. Conditions of oxygen deprivation (for example shock, heart failure, lung disease) will trigger anaerobic metabolism within muscle tissue resulting in lactic acid build up in the tissues. Normal lactic acid levels are 4.5 to 19.8 mg/dl.
(27 Sep 1997)
lactic acid level <investigation> A test that measures the amount of lactic acid in the blood.
(25 Jun 1999)
free calcium level <biochemistry> The ionised calcium represents the calcium (Ca++) that is the metabolically active calcium. Normal values for ionised calcium in the bloodstream should be 4.4 to 5.3 mg/dl for adults and 4.4 to 6.0 mg/dl for children. Elevations may be seen in hyperparathyroidism, metastatic bone tumour, milk-alkali syndrome, multiple myeloma, Paget's disease, sarcoidosis, PTH-secreting tumours (paraneoplastic syndrome) and vitamin D intoxication. Lower than normal values may be seen in hypoparathyroidism, malabsorption, osteomalacia, pancreatitis, renal failure, rickets and vitamin D deficiency.
(27 Sep 1997)
level of aspiration <psychology> The degree or quality of performance (exhibited in a testing situation) which an individual desires to attain or feels he can achieve.
(05 Mar 2000)
abbreviated injury scale Classification system for assessing impact injury severity developed and published by the american association for automotive medicine. It is the system of choice for coding single injuries and is the foundation for methods assessing multiple injuries or for assessing cumulative effects of more than one injury. These include maximum ais (mais), injury severity score (iss), and probability of death score (pods).
(12 Dec 1998)
axillary nerve injury <neurology> A condition involving dysfunction of the axillary nerve which normally supplies the deltoid and teres minor muscles and sensation to the lateral aspect of the shoulder.
This condition is a type of peripheral neuropathy that may manifest as the result of a variety of disease processes or injuries. Conditions associated with axillary nerve dysfunction include mononeuritis multiplex, fracture of the humerus, abduction injury to the shoulder, pressure to the armpit from a cast, splint or crutches.
Symptoms include numbness over the outer portion of the shoulder, shoulder weakness and difficulty lifting arm or objects over your head. An EMG, nerve conduction study or muscle biopsy can be helpful in making the diagnosis. Recovery is generally spontaneous if the underlying cause can be corrected and shoulder mobility is preserved. Corticosteroid injections may be indicated in some instances.
(02 Jan 1998)
blast injury Tearing of lung tissue or rupture of abdominal viscera without external injury, as by the force of an explosion.
(05 Mar 2000)
brain injury Acute injuries to the brain, general or unspecified.
(12 Dec 1998)
reperfusion injury Functional, metabolic, or structural changes, including necrosis, in ischemic tissues thought to result from reperfusion to ischemic areas of the tissue. The most common instance is myocardial reperfusion injury.
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • A level
    »ó±ÞÇгâ½ÃÇè
  • O-level
    ±âÃÊÇз½ÃÇè
  • club floor(level)
    (È£ÅÚÀÇ)±Íºó¿ë Ç÷ξî;ȣȭ°´½ÇÇ÷ξî(º¸Åë È£ÅÚÀÇ ÃÖ»óÃþ)
  • constant-level balloon
    Á¤ °íµµ±â±¸
  • dumpy level
    ¸Á¿ø°æÀÌ ´Þ¸° ¼öÁرâ
  • fog level
    (Çö»óµÈ Çʸ§ÀÇ) ¹Ì³ëÃâ ³óµµ
  • level
    ¼öÆòÀÇ;ÆòÆòÇÑ;µ¿ÀÏ ¼öÁØÀÇ;¼­·Î ¿ì¿­ÀÌ ¾ø´Â;ÇѰᰰÀº;ºÐº°ÀÖ´Â;do one's ~ best Àü·ÂÀ» ´ÙÇÏ´Ù
  • level
    ¼öÆò(¸é);ÆòÁö;³ôÀÌ;¼öÁØ;find one's(its)~ ½Ç·Â¿¡ ¸Â´Â ÁöÀ§¸¦ ¾ò´Ù;on a ~ with ...°ú µ¿µîÇϰÔ;on the ~ °øÁ¤ÇÑ
  • level
    °Ü´©´Ù;Á¶ÁØÇÏ´Ù;~ down(up)(...ÀÇ Ç¥ÁØÀ») ³·Ãß´Ù(¿Ã¸®´Ù)
  • level
    ¼öÆòÀ¸·Î ¸¸µé´Ù;°í¸£´Ù;µ¿ÀÏ ¼öÁØÀ¸·Î ¸¸µé´Ù;(°Ç¹°À») ¾²·¯¶ß¸®´Ù;(Àǵµ¸¦) µ¹¸®´Ù
  • mean sea level
    Æò±Õ ÇØ¸é(ÇØ¹ß ±âÁØ)
  • ordinary level
    G;C;E;ÀÇ ±âÃÊ Çз ½ÃÇè
  • replacement level
    Àα¸ º¸Ãæ ¼öÁØ(ÃÑÀα¸¸¦ À¯ÁöÇÏ´Â µ¥¿¡ ÇÊ¿äÇÑ Ãâ»ý·ü)
  • resistance level
    (½Ã¼¼ÀÇ)ÀúÇ×¼±(½Ã¼¼°¡ ÁÁ±â ¶§¹®¿¡ ÆÇ¸Å°¡ Ȱ¹ßÇØÁ®,±× ÀÌ»óÀÇ ½Ã¼¼ »ó½ÂÀÌ µÐÇØÁö´Â °¡°Ý ¼öÁØ)
  • sea level
    ÇØ¸é
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á